Details of the Drug

General Information of Drug (ID: DMPCSTM)

Drug Name

Gamma-sarcoglycan gene-containing recombinant AAV1 vector based therapy

Synonyms

Gamma-sarcoglycan gene-containing recombinant AAV1vector based therapy (limb-girdle muscular dystrophy type 2C)

Indication

Disease Entry	ICD 11	Status	REF
Duchenne dystrophy	8C70	Phase 2	[1]
------------------------------------------------------------------------------------

Cross-matching ID

References

1	Gene replacement therapies for duchenne muscular dystrophy using adeno-associated viral vectors. Curr Gene Ther. 2012 Jun;12(3):139-51.